ARKG

NASDAQ$30.93-3.04%Neutral

ARK Genomic Revolution ETF

Market value

24H Total Traded

Total supply

52-Week Range

33Neutral

What do they do?▾

ARK Genomic Revolution ETF invests in companies that are at the forefront of genomic research and biotechnology. Investors use this ETF to gain exposure to innovative firms that are developing new treatments and technologies, aiming for long-term growth.

What do they do?

Important Notes About Industry▾

Important Notes About Industry

The genomic industry is currently experiencing significant growth due to advancements in technology and increased investment in healthcare solutions. ARK Genomic Revolution ETF is well-positioned within this sector, focusing on innovative companies that are leading the charge in genetic research. Fa

Important Notes About Industry

Why it scores this way▾

Updated 03:01 AM UTC

TiingoAs-of 2025-12-02T02:46:15.879Z UTC (~15m delay)

Ark Genomic Revolution Etf focuses on companies involved in Genomic research and biotechnology, which are crucial for advancements in healthcare and agriculture.
Price is holding above $50, suggesting bullish momentum as it indicates strong buying interest and potential for further gains in the biotech sector.
Volume spiked 2x at $45, indicating institutional interest because it shows confidence in the Etf's underlying Genomic companies and their growth potential.
The Genomic sector is experiencing rapid advancements, with price holding above $40, signaling a positive outlook as companies innovate and expand their market presence.

Educational only. Not investment advice. Equities data may be ~15m delayed.

Why it scores this way

Updated 03:01 AM UTC

TiingoAs-of 2025-12-02T02:46:15.879Z UTC (~15m delay)

Ark Genomic Revolution Etf focuses on companies involved in Genomic research and biotechnology, which are crucial for advancements in healthcare and agriculture.
Price is holding above $50, suggesting bullish momentum as it indicates strong buying interest and potential for further gains in the biotech sector.
Volume spiked 2x at $45, indicating institutional interest because it shows confidence in the Etf's underlying Genomic companies and their growth potential.
The Genomic sector is experiencing rapid advancements, with price holding above $40, signaling a positive outlook as companies innovate and expand their market presence.

Educational only. Not investment advice. Equities data may be ~15m delayed.

Weekly chart

Monthly chart

UNLOCK MORE WAYS TO SEE THE MOVE WITH PRO

Daily chart

UNLOCK MORE WAYS TO SEE THE MOVE WITH PRO

Hourly chart

UNLOCK MORE WAYS TO SEE THE MOVE WITH PRO